Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 2023 ASCO Gastrointestinal Cancers Symposium will host world-renowned experts in gastrointestinal cancers and this international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of gastrointestinal cancers. Watch exclusive interviews from ASCO GI 2023 to keep up to date with the latest in gastrointestinal cancers!
View all videos

ASCO GI 2023

ASCO Gastrointestinal Cancers Symposium 2023
19–21 January 2023 | San Francisco, CA

#ESMO26 | Xing Zhang shares results from a Phase II study of nab-paclitaxel + pegylated liposomal doxorubicin in advanced or unresectable malignant vascular tumors, including #angiosarcoma 💉📈

The combination achieved an ORR of around 50% and a PFS of around 8 months, and

It was lovely to speak with Yeon Hee Park at #ESMO26 to discuss strategic treatment sequencing in HR+ metastatic #BreastCancer 🧬🎯

She explores how disease-free interval, prior treatment, biomarkers and the choice of endocrine backbone and CDK4/6 inhibitor in the first line can

What’s next in HER2-mutant #NSCLC? 🧬

This #lungcancer awareness month, Joshua Sabari explores emerging combination strategies, balancing efficacy with toxicity and patient-reported outcomes, and the potential of brain-penetrant TKIs such as NVL-330.

▶️ Watch the interview:

Want to gain insight into the role of total neoadjuvant therapy in locally advanced #RectalCancer? 🩺💪

Check out our recent interview with Sara Lonardi (@sara_lonardi1) from #ESSO45, where she explains how delivering #chemotherapy and #radiotherapy before surgery offers a more

At #ESMO26, Ariane Steindl shares findings from a study of around 150 patients with progressive #BrainMetastases, in which those who received #radiotherapy before progression had lower TIL infiltration and higher levels of the immunosuppressive marker FOXP3 🧠☢️

Watch:

ASCO GI 2023

ASCO Gastrointestinal Cancers Symposium 2023
19–21 January 2023 | San Francisco, CA
The 2023 ASCO Gastrointestinal Cancers Symposium will host world-renowned experts in gastrointestinal cancers and this international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of gastrointestinal cancers. Watch exclusive interviews from ASCO GI 2023 to keep up to date with the latest in gastrointestinal cancers!
View all videos

#ESMO26 | Xing Zhang shares results from a Phase II study of nab-paclitaxel + pegylated liposomal doxorubicin in advanced or unresectable malignant vascular tumors, including #angiosarcoma 💉📈

The combination achieved an ORR of around 50% and a PFS of around 8 months, and

It was lovely to speak with Yeon Hee Park at #ESMO26 to discuss strategic treatment sequencing in HR+ metastatic #BreastCancer 🧬🎯

She explores how disease-free interval, prior treatment, biomarkers and the choice of endocrine backbone and CDK4/6 inhibitor in the first line can

What’s next in HER2-mutant #NSCLC? 🧬

This #lungcancer awareness month, Joshua Sabari explores emerging combination strategies, balancing efficacy with toxicity and patient-reported outcomes, and the potential of brain-penetrant TKIs such as NVL-330.

▶️ Watch the interview:

Want to gain insight into the role of total neoadjuvant therapy in locally advanced #RectalCancer? 🩺💪

Check out our recent interview with Sara Lonardi (@sara_lonardi1) from #ESSO45, where she explains how delivering #chemotherapy and #radiotherapy before surgery offers a more

At #ESMO26, Ariane Steindl shares findings from a study of around 150 patients with progressive #BrainMetastases, in which those who received #radiotherapy before progression had lower TIL infiltration and higher levels of the immunosuppressive marker FOXP3 🧠☢️

Watch:

Genomic biomarkers in metastatic colorectal cancer

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.